Riik: Uus-Meremaa
keel: inglise
Allikas: Medsafe (Medicines Safety Authority)
Estradiol 0.312 mg/cm² equivalent to 25 µg/24h;
iNova Pharmaceuticals (New Zealand) Limited
Estradiol 0.312 mg/cm² (=25 µg/24h)
25 mcg/24h
Transdermal patch
Active: Estradiol 0.312 mg/cm² equivalent to 25 µg/24h Excipient: Acrylates copolymer Ethyl oleate Glyceryl monolaurate Isopropyl myristate
Sachet, aluminium foil, Laminated, 4 patches
Prescription
Prescription
NV Organon
Package - Contents - Shelf Life: Sachet, aluminium foil, Laminated - 4 patches - 36 months from date of manufacture stored at or below 30°C
1999-01-07
Medsafe Logo INFORMATION FOR CONSUMERS Home | Consumers | Health Professionals | Regulatory | Other | Hot Topics | Search Consumer Medicine Information Femtran™ Estradiol Transdermal Delivery System FOR OESTROGEN REPLACEMENT THERAPY What is in this Leaflet This leaflet answers some common questions about Femtran. But it does not contain all the available information. Your doctor and pharmacist have more detailed information about Femtran patches. So if you need any more information about Femtran please ask your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risk of your using Femtran against the benefits it can have for you. If you have any concerns about using this medicine ask your doctor or pharmacist. Keep this leaflet with the medicine as you may want to read it again. Your Medicine The name of your medicine is FEMTRAN. FEMTRAN is a patch made of thin, clear plastic covered with a layer of adhesive which contains the active ingredient estradiol (17-beta estradiol). This type of patch is called a Transdermal Delivery System. FEMTRAN patches are covered by a protective liner which should be taken off before sticking the patch onto the skin. Estradiol, the active ingredient in Femtran, is a female sex hormone. Estradiol is a type of oestrogen. Oestrogens are produced by the ovaries during the child-bearing years of a woman's life. When you apply a Femtran patch to your skin estradiol passes through the skin into the blood stream gradually and constantly over the course of a whole week. Because the medicine does not have to pass through your stomach and liver you can use a much lower dose than would be needed in a tablet. What Femtran is used for What Femtran is used for Femtran is used Lugege kogu dokumenti
Medsafe Logo INFORMATION FOR HEALTH PROFESSIONALS Home | Consumers | Health Professionals | Regulatory | Other | Hot Topics | Search Data Sheet FEMTRAN™ 25 Estradiol USP 2.0 mg per transdermal patch FEMTRAN™ 50 Estradiol USP 3.8 mg per transdermal patch FEMTRAN™ 100 Estradiol USP 7.6 mg per transdermal patch Presentation FEMTRAN is a transdermal delivery system containing estradiol as the active ingredient. Estradiol is estra-1,3,5(10)-triene-3, 17beta-diol, the major oestrogenic hormone produced by the human ovary. The CAS Registry number for estradiol is 50-28-2. The FEMTRAN transdermal delivery system is a transparent oval patch containing estradiol in an adhesive matrix. Three strengths of FEMTRAN are available: 25, 50 and 100. 25 50 100 Estradiol content: 2mg 3.8mg 7.6mg Size (release area): 6.5cm² 12.5cm² 25cm² Nominal daily in-vivo release of estradiol 25mcg 50mcg 100mcg When applied to intact skin, transdermal delivery from FEMTRAN patches is maintained over 7 days. Transdermal delivery of estradiol overcomes the problems of its short half-life, seen when estradiol is Transdermal delivery of estradiol overcomes the problems of its short half-life, seen when estradiol is given orally, due to extensive first pass metabolism. The FEMTRAN transdermal delivery system is comprised of two layers. 1. A backing layer of translucent polyethylene film 2. Estradiol in an adhesive matrix. A protective liner is attached to the adhesive surface. This must be removed prior to applying the patch to the skin. The excipients of the FEMTRAN transdermal delivery system include acrylate copolymer adhesive, fatty acid esters and polyethylene backing. FEMTRAN patches do not contain alcohol. Uses Actions FEMTRAN provides systemic oestrogen replacement therapy by releasing est Lugege kogu dokumenti